Skip to content

Author

E. Abraham

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Pulmonary Nocardiosis in a Post-Tuberculosis Patient

Pulmonary nocardiosis is an uncommon but potentially life-threatening opportunistic infection caused by aerobic actinomycetes of the genus Nocardia. Owing to its nonspecific clinical and radiological manifestations, it frequently mimics pulmonary tuberculosis, bacterial pneumonia, and fungal infections, often resulting in delayed diagnosis and treatment. We report the case of a 52-year-old immunocompetent female with a history of successfully treated pulmonary tuberculosis who presented with cough with expectoration, fever, chest pain, and loss of appetite. Clinical examination revealed bilateral decreased breath sounds with occasional wheeze. Laboratory investigations demonstrated neutrophilic leukocytosis, while conventional acid-fast bacilli staining was negative. Computed tomography of the chest showed bilateral upper lobe cavitary consolidations with multiple centrilobular nodules and a tree-in-bud appearance, initially raising suspicion of recurrent pulmonary tuberculosis. However, modified acid-fast staining of sputum demonstrated thin, branching filamentous organisms consistent with Nocardia species, establishing the diagnosis of pulmonary nocardiosis. Bronchoalveolar lavage culture was negative, likely due to prior antibiotic exposure. The patient was treated with weight-adjusted double-strength trimethoprim-sulfamethoxazole, resulting in marked clinical improvement and significant radiological resolution on follow-up. This case emphasizes the importance of maintaining a high index of suspicion for pulmonary nocardiosis in patients with post-tuberculous structural lung disease who present with persistent respiratory symptoms and cavitary pulmonary lesions despite negative acid-fast bacilli results. Early microbiological confirmation using modified acid-fast staining and prompt initiation of appropriate antimicrobial therapy are crucial to prevent dissemination and improve clinical outcomes, particularly in tuberculosis-endemic regions where nocardiosis remains an underrecognized differential diagnosis.

A. A., S. K., E. Abraham et al. · 0 citations
Open access Aug 2026

Nocturnal Hypoxemia As A Marker Of Disease Severity In Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Background: Nocturnal oxygen desaturation (NOD) is a common but underrecognized phenomenon in chronic obstructive pulmonary disease (COPD), contributing to disease progression and adverse clinical outcomes. Its association with disease severity and clinical predictors remains inadequately explored in resource-limited settings. Methods: A hospital-based cross-sectional analytical study was conducted from August 2025 to January 2026 among 100 clinically stable COPD patients. Data on demographic and clinical variables were collected, and COPD severity was classified using GOLD criteria. Nocturnal oxygen desaturation was assessed using overnight pulse oximetry, while exercise-induced desaturation was evaluated using the six-minute walk test (6-MWT). Statistical analysis was performed using SPSS version 26.0. Associations were assessed using chi-square test, and predictors were identified using univariate and multivariate logistic regression. Results: The prevalence of nocturnal oxygen desaturation was 58%. NOD increased significantly with COPD severity, from 16.7% in GOLD I to 90.9% in GOLD IV (p<0.001). On multivariate analysis, independent predictors of NOD included age >60 years (AOR 1.8, p=0.03), smoking (AOR 2.6, p=0.004), BMI <18.5 kg/m² (AOR 2.1, p=0.02), COPD duration ≥5 years (AOR 1.9, p=0.04), GOLD stage III–IV (AOR 3.5, p<0.001), and 6-MWT desaturation (AOR 5.2, p<0.001). Conclusion: Nocturnal oxygen desaturation is highly prevalent in COPD and strongly associated with disease severity and key clinical factors. Early identification using simple screening tools such as pulse oximetry and 6-MWT may facilitate timely intervention and improve clinical outcomes.

Thirumagal R, E. Abraham, Ghanshyam Verma · 0 citations